Biomet Posts 9% Sales Increase in 2013 2Q

Biomet’s net sales increased by 9 percent to $790.1 million in the second quarter of the 2013 fiscal year, compared with $725.1 million during the second quarter of last year.

Advertisement

U.S. net sales increased by 10 percent to $470.8 million.

Large joint reconstructive sales increased by 2 percent in the U.S. and 1 percent worldwide. Spine increased by 7 percent in the U.S. and 4 percent worldwide.

Sports, extremities and trauma increased by 74 percent to $152.2 million, due to a trauma acquisition.

More Articles on Devices:
Drs. R. Alexander Creighton & Clifford Wheeless Perform New Joint Replacement Procedures
Mahr Federal Unveils Mobile Surface Measuring Device
TranS1 Reports $4.1M 4Q Revenue, Up 3%

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.